Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05626088 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT05626088 · ClinicalTrials.gov record · last posted 2026-08-07

A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in Brazil

Name: A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in Brazil — clinical trial record (NCT05626088)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusCompleted

PhaseNot specified

SponsorTakeda

Started2023-04-10

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

The primary reason of this study is to observe current and past treatment in adult participants receiving Vedolizumab, intravenous (IV) or subcutaneous (SC), for IBD in Brazil. There is no treatment involved in this study, this is only an observational review of past and ongoing treatment data relating to Vedolizumab treatment for IBD (including Ulcerative Colitis \[UC\] and Crohn's Disease \[CD\]).

Protocol amendment history 2 changes detected by DataLookout

2026-08-08

Trial completed

2026-05-27

Completion pushed: 2026-05-29 → 2026-06-30

Trial Details

NCT Number	NCT05626088
Lead Sponsor	Takeda
Conditions	Ulcerative Colitis, Crohn's Disease
Enrollment	1,006 participants
Start Date	2023-04-10
Primary Completion	2024-12-27 (estimated)
Study Completion	2026-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-07